Immunoglobulin E (IgE) (IgE)

Polyclonal IgE antibodies against German cockroach allergens represent a specific subset of the immunoglobulin E class produced by the immune system in response to proteins from Blattella germanica. These antibodies play a central role in the pathogenesis of allergic diseases, particularly asthma and allergic rhinitis in urban environments where cockroach sensitization is prevalent. Upon exposure to cockroach allergens (such as Bla g 1 or Bla g 2), these specific IgE molecules, which are typically bound to high-affinity FcεRI receptors on mast cells and basophils, trigger cross-linking and subsequent degranulation. This process releases potent inflammatory mediators like histamine and leukotrienes, leading to acute and chronic airway inflammation. In clinical practice, these antibodies serve as both diagnostic biomarkers and therapeutic targets; for instance, monoclonal antibodies like Omalizumab sequester free IgE to prevent the allergic cascade, while allergen-specific immunotherapy aims to modulate the immune system to reduce the production of these specific polyclonal antibodies.

Other names

German cockroach allergen-specific IgEBlattella germanica-specific IgEAntigen-specific IgEReaginic antibody

Anti-IgE monoclonal antibodies bind to the Cε3 domain of the Fc region of free IgE, preventing its interaction with the high-affinity IgE receptor (FcεRI) on mast cells and basophils, thereby inhibiting the release of inflammatory mediators.